BioStock: PHI aims for US listing

July 11, 2024
Language flag

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing regenerative medicine field. PHI is now taking an important step by applying for listing its shares in the US OTCQB market to enhance its presence and opportunities in the US. BioStock talked to CEO Patrik Eschricht to learn more about what this means for the company.

Read the full interview with Patrik Eschricht on biostock.se.

We are very happy about the possibility of dual-listing on the OTCQB, which would be another significant step in PHI’s growth journey as a global company. This dual listing would make it more accessible for international investors to invest in PHI, positively increasing liquidity, boosting shareholder value, and supporting our ongoing growth.

Further reading

righst issue of units 2022 banner

BioStock: The five best life science stocks of the first half-year

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
PHI-worldtour-1024x576

BioStock: PHI’s CEO reflects on global roadshow success

BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.
Biostock-PHI-on-how-TO-3-proceeds-will-be-used

BioStock: PHI on how TO 3 proceeds will be used

BioStock talked to CEO Patrik Eschricht to learn how the TO 3 proceeds would be used.
PHI_progress-1024x576-1

BioStock: PHI´s CEO comments on latest advancements

BioStock reached out to PHI´s CEO, Patrik Eschricht, to learn more about the visions moving forward.
1…5678910

Latest News

Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ) 8 January 2025

Phase Holographic Imaging PHI AB (publ), held a general meeting on 8 January 2025. The following resolutions were made.

PHI announces outcome of rights issue
Peter Egelberg CEO PHI

Founder and board member subscribes for shares in the ongoing rights issue

Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.
See All News